Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Change in Cash (2017 - 2025)

Selectis Health's Change in Cash history spans 14 years, with the latest figure at -$107912.0 for Q3 2025.

  • For Q3 2025, Change in Cash rose 95.1% year-over-year to -$107912.0; the TTM value through Sep 2025 reached -$598585.0, up 52.07%, while the annual FY2024 figure was -$912757.0, 715.86% down from the prior year.
  • Change in Cash for Q3 2025 was -$107912.0 at Selectis Health, up from -$693775.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $2.0 million in Q2 2024 and bottomed at -$2.2 million in Q3 2024.
  • The 5-year median for Change in Cash is -$216857.0 (2023), against an average of -$144962.7.
  • The largest YoY upside for Change in Cash was 758.31% in 2022 against a maximum downside of 1462.34% in 2022.
  • A 5-year view of Change in Cash shows it stood at $1.2 million in 2021, then tumbled by 129.13% to -$343559.0 in 2022, then crashed by 123.15% to -$766656.0 in 2023, then skyrocketed by 43.83% to -$430630.0 in 2024, then skyrocketed by 74.94% to -$107912.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Change in Cash are -$107912.0 (Q3 2025), -$693775.0 (Q2 2025), and $633732.0 (Q1 2025).